2006
DOI: 10.1055/s-2006-925253
|View full text |Cite
|
Sign up to set email alerts
|

Endoscopic Ultrasound-Guided Interstitial Brachytherapy of Unresectable Pancreatic Cancer: Results of a Pilot Trial

Abstract: EUS-guided intraoperative interstitial brachytherapy had a moderate local tumor effect and showed some clinical benefit in 30% of the patients in this study. Combination of this form of treatment with external radiation and/or chemotherapy should be tested in future trials.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
78
0
1

Year Published

2011
2011
2022
2022

Publication Types

Select...
4
4
2

Relationship

0
10

Authors

Journals

citations
Cited by 144 publications
(82 citation statements)
references
References 3 publications
3
78
0
1
Order By: Relevance
“…15,16 The number of patients enrolled in these two studies was 15 and 22, respectively, with stage III or IV pancreatic cancer in a majority of cases. The study conducted by Sun et al 15 reported an estimated median survival time of 10.6 months and 27% patients reached a partial tumor response toward a mean 22 seeds load per patient. Procedure-related pancreatitis or pseudocyst was only found in three patients, which was considered mild and easily managed.…”
Section: Eus-guided Iodine-125 Implantation In Pancreatic Cancermentioning
confidence: 99%
“…15,16 The number of patients enrolled in these two studies was 15 and 22, respectively, with stage III or IV pancreatic cancer in a majority of cases. The study conducted by Sun et al 15 reported an estimated median survival time of 10.6 months and 27% patients reached a partial tumor response toward a mean 22 seeds load per patient. Procedure-related pancreatitis or pseudocyst was only found in three patients, which was considered mild and easily managed.…”
Section: Eus-guided Iodine-125 Implantation In Pancreatic Cancermentioning
confidence: 99%
“…Other series of intraoperative iodine−125 implantation have been associated with mortality ranging from 0% to 16% and major morbidity of 18% (Order et al, 1996). Sun S et al reported (Sun et al, 2006), there was no significant immediate complications, such as significant bleeding or infection. The incidence of complications was 3/15 (20%), and the adverse events were mild and not life−threatening.…”
Section: Wwwintechopencommentioning
confidence: 99%
“…Other reported complications reported less frequently are pancreatitis and pseudocyst formation. (Sun et al, 2006) Small size studies have demonstrated the technical feasibility of EUS-guided implantation of radioactive seeds in pancreatic tumors, and the technique appears to be well tolerated. (Ramesh & Varadarajulu, 2008;Sun et al, 2006) However, larger studies evaluating this technique and its role in a multimodality approach in combination with chemotherapy and/ or external beam radiation are needed.…”
Section: Therapeutic Interventionsmentioning
confidence: 99%